The putative tumour suppressor EXT1 alters the expression of cell- surface heparan sulfate

Nature Genetics

Volumn 19, Issue 2, 1998, Pages 158-161

  McCormick, Craig ^a   Leduc, Yves ^a   Martindale, Diane ^a   Mattison, Kirsten ^a   Esford, Lesley E ^a   Dyer, Angela P ^a   Tufaro, Frank ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHONDROSARCOMA; CLINICAL FEATURE; DISEASE ASSOCIATION; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; MALIGNANT TRANSFORMATION; MISSENSE MUTATION; OSTEOSARCOMA; PRIORITY JOURNAL; SHORT STATURE; TUMOR SUPPRESSOR GENE;

EID: 0031837107     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/514     Document Type: Article

References (30)

1. Solomon, L. Hereditary multiple exostosis. J. Bone Joint Surg. 45, 292-304 (1963).
2. Hennekam, R.C. Hereditary multiple exostoses. J. Med. Genet. 28, 262-266 (1991).
3. Leone, N.C. et al. Hereditary multiple exostosis. A comparative human-equine-epidemiologic study. J. Hered. 78, 171-177 (1987).
4. Schmale, G.A., Conrad, E.U. & Raskind, W.H. The natural history of hereditary multiple exostoses. J. Bone Joint Surg. Am. 76, 986-992 (1994).
5. Luckert-Wicklund, C., Pauli, R., Johnston, D. & Hecht, J. Natural history of hereditary multiple exostoses. Am. J. Med. Genet. 55, 43-46 (1995).
6. Ahn, J. et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nature Genet. 11, 137-143 (1995).
7. Cook, A. et al. Genetic heterogeneity in families with hereditary multiple exostoses. Am. J. Hum. Genet. 53, 71-79 (1993).
8. LeMerrer, M. et al. A gene for hereditary multiple exostoses maps to chromosome 19p. Hum. Mol. Genet. 3, 717-722 (1994).
9. Wu, Y.Q. et al. Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum. Mol. Genet 3, 167-171 (1994).
10. Philippe, C. et al. Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses. Am. J. Hum. Genet. 61, 520-528 (1997).
11. WuDunn, D. & Spear, P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63, 52-58 (1989).
12. Herold, B.C., Visalli, R.J., Susmarski, N., Brandt, C.R. & Spear, P.G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75, 1211-1222 (1994).
13. Herold, B.C., WuDunn, D., Soltys, N. & Spear, P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65, 1090-1098 (1991).
14. Cai, W., Gu, B. & Person, S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62, 2596-2604 (1988).
15. Banfield, B.W., Leduc, Y., Esford, L., Schubert, K. & Tufaro, F. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69, 3290-3298 (1995).
16. Gruenheid, S., Gatzke, L., Meadows, H. & Tufaro, F. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67, 93-100 (1993).
17. Schutze, M.P., Peterson, P.A. & Jackson, M.R. An N-terminal doubte-arginine motif maintains type II membrane proteins in the endoplasmic retiuculum. EMBO J. 13, 1696-1705 (1994).
18. Teasdale, R.D. & Jackson, M.R. Signal-Mediated Sorting of Membrane Proteins Between the Endoplasmic Reticulum and the Golgi Apparatus. Annu. Rev. Cell Dev. Biol. 12, 27-54 (1996).
19. Hecht, J.T. et al. Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am. J. Hum. Genet. 60, 80-86 (1997).
20. Bernstein, L.R. & Liotta, L.A. Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr. Opin. Oncol. 6, 106-113 (1994).
21. Tuszynski, G.P., Wang, T.N. & Berger, D. Adhesive proteins and the hematogenous spread of cancer. Acta Haematol. 97, 29-39 (1997).
22. Schamhart, D.H. & Kurth, K.H. Role of proteoglycans in cell adhesion of prostate cancer cells: from review to experiment. Urol. Res. 25, 589-96 (1997).
23. Esko, J.D., Rostand, K.S. & Weinke, J.L. Tumour formation dependent on proteoglycan biosynthesis. Science 241, 1092-1096 (1988).
24. Iida, J., Meijne, A.M., Knutson, J.R., Furcht, L.T. & McCarthy, J.B. Cell surface chondroitin sulfate proteoglycans in tumour cell adhesion, motility and invasion. Semin. Cancer Biol. 7, 155-162 (1996).
25. Iozzo, R.V. & Cohen, I. Altered proteoglycan gene expression and the tumour stroma. Experientia 49, 447-455 (1993).
26. Wise, C.A., Clines, G.A., Massa, H., Trask, B.J. & Lovett, M. Identification and localization of the gene for EXTL a third member of the multiple exostoses gene family. Genome Res. 7, 10-16 (1997).
27. Wuyts, W. et al. Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur. J. Hum. Genet. 5, 382-389 (1997).
28. Van Hul, W. et al. Identification of a Third EXT-like Gene (EXTL3) Belonging to the EXT Gene Family. Genomics 47, 230-237 (1998).
29. Esko, J.D., Stewart, T.E. & Taylor, W.H. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA 82, 3197-3201 (1985).
30. Bame, K.J. & Esko, J.D. Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J. Biol. Chem. 264, 8059-8065 (1989).